Abiopharma

Financial Statements and Related Announcement: Half Yearly Results

Change in holdings of interested parties/officers

Financial Statements and Related Announcement: First Quarter Results

New Form FWP - CITIGROUP INC <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001918704-26-012542 <b>Size:</b> 90 KB

Xeriant Launches NexPatch™ Fire-Resistant Joint Compound that Seamlessly Extends NEXBOARD™ Fire Protection

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001918704-26-012541 <b>Size:</b> 880 KB

New Form SCHEDULE 13G/A - Rein Therapeutics, Inc. <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001697316-26-000012 <b>Size:</b> 101 KB

New Form 424B2 - UBS AG <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001839882-26-023385 <b>Size:</b> 885 KB

General Announcement: Announcement by BRC Asia Limited ("BRC")

Niagen Bioscience Announces Participation in Upcoming Investor Conferences

Director Bunina Elena 🔴 sold 10.8K shares of Nebius Group N.V. (NBIS) at $190.00 ($2.0M) Transaction Date: May 06, 2026 | Filing ID: 000055

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001918704-26-012540 <b>Size:</b> 809 KB

(30% Negative) BIOAFFINITY TECHNOLOGIES, INC. (BIAFW) Reports Q2 2026 Financial Results

(99% Neutral) STRAN & COMPANY, INC. (SWAGW) Files Form 8-K

bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung